Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy.

MLA

Uberti-Foppa, Caterina, et al. “Pretreatment of Chronic Active Hepatitis C in Patients Coinfected with HIV and Hepatitis C Virus Reduces the Hepatotoxicity Associated with Subsequent Antiretroviral Therapy.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 33, no. 2, June 2003, pp. 146–52. EBSCOhost, https://doi.org/10.1097/00126334-200306010-00005.

APA

Uberti-Foppa, C., De Bona, A., Morsica, G., Galli, L., Gallotta, G., Boeri, E., & Lazzarin, A. (2003). Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999), 33(2), 146–152. https://doi.org/10.1097/00126334-200306010-00005

Chicago

Uberti-Foppa, Caterina, Anna De Bona, Giulia Morsica, Laura Galli, Giulia Gallotta, Enzo Boeri, and Adriano Lazzarin. 2003. “Pretreatment of Chronic Active Hepatitis C in Patients Coinfected with HIV and Hepatitis C Virus Reduces the Hepatotoxicity Associated with Subsequent Antiretroviral Therapy.” Journal of Acquired Immune Deficiency Syndromes (1999) 33 (2): 146–52. doi:10.1097/00126334-200306010-00005.